HOOKIPA PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8873 USD | -5.71% |
|
+15.99% | +9.54% |
| 25/04 | Transcript : HOOKIPA Pharma Inc. - Special Call | |
| 25/04 | HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab | CI |
Chart calendar HOOKIPA Pharma Inc.
04b2de45.BxzT4H_sOLHlnnmsEGoeAsBAOqmH6Hn_uay8IJD-vsA.SX6xhx6VTeWr2i_YXzItWpR5U8vvrjiy3uTFQuW16YhfeLWrT5RUxI39Fg~5741d314cd87c10914ec0dc354ddef64
Upcoming events on HOOKIPA Pharma Inc.
Past events on HOOKIPA Pharma Inc.
| 25/04/2024 05:30 pm | HOOKIPA HB-200 Phase 2 Trial Results Call |
| 22/03/2024 04:31 pm | Q4 2023 Earnings Release |
| 13/03/2024 06:50 pm | Leerink Partners Global Biopharma Conference |
| 09/11/2023 05:31 pm | Q3 2023 Earnings Release |
| 12/09/2023 09:00 pm | H.C. Wainwright Global Investment Conference |
| 12/09/2023 01:05 am | Morgan Stanley Global Healthcare Conference |
| 10/08/2023 04:31 pm | Q2 2023 Earnings Release |
| 09/06/2023 07:30 pm | Annual General Meeting |
| 03/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Abstract No #TPS5108 |
| 01/06/2023 05:30 pm | Business Update Call |
| 16/05/2023 11:05 pm | RBC Capital Markets Global Healthcare Conference |
| 16/05/2023 12:30 am | JMP Securities Life Sciences Conference |
| 11/05/2023 04:33 pm | Q1 2023 Earnings Release |
| 09/05/2023 | Bank of America Healthcare Conference |
| 25/04/2023 | Van Lanschot Kempen Life Sciences Conference |
| 14/04/2023 | American Association for Cancer Research Meeting |
| 15/03/2023 06:00 pm | Q4 2022 Earnings Call |
| 15/03/2023 04:30 pm | Q4 2022 Earnings Release |
| 14/02/2023 08:30 pm | SVB Securities Global Biopharma Conference |
| 06/12/2022 | JMP Securities Hematology Oncology Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,9 11,2 6.61% | 19,6 18,7 4.87% | 18,4 18,7 -1.18% | 14,2 11,2 27.02% | 20,1 17,3 16.58% | 30,8 |
|
EBITDA Million USD | Released Forecast Spread | -49,6 -49,1 -1.17% | -49,1 -54,8 10.41% | -77,0 -73,3 -5.12% | -69,6 -60,9 -14.17% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -51,1 -50,7 -0.79% | -53,3 -54,2 1.76% | -81,7 -79,4 -2.84% | -73,2 -74,1 1.22% | -97,7 -89,8 -8.79% | -54,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -44,1 -46,1 4.37% | -75,7 -77,4 2.29% | -64,7 -71,7 9.76% | -81,2 -79,5 -2.13% | -79,4 |
|
Net income Million USD | Released Forecast Spread | -43,0 -40,0 -7.54% | -44,1 -48,3 8.79% | -75,7 -76,2 0.64% | -64,9 -67,7 4.11% | -81,6 -80,2 -1.75% | -63,6 |
|
EPS USD | Released Forecast Spread | -2,41 -2,73 11.72% | -1,69 -1,88 10.3% | -2,30 -2,32 0.78% | -0,99 -1,08 8.67% | -0,86 -0,79 -8.86% | -0,46 |
| Announcement Date | 19/03/20 | 18/03/21 | 24/03/22 | 15/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,90 3,80 2.38% | 1,45 14,5 -90.06% | 2,75 3,36 -18.18% | 2,23 2,91 -23.31% | 7,83 3,27 139.61% | 3,18 4,51 -29.62% | 2,68 4,84 -44.68% | 6,87 4,25 61.42% | 7,41 4,56 62.6% | 5,22 | 12,2 | 6,64 | 6,74 | 2,00 |
|
EBITDA Million USD | Released Forecast Spread | -20,8 -22,5 7.56% | -12,7 1,61 -887.87% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -22,0 -22,2 0.55% | -20,1 -12,6 -59.64% | -18,4 -19,9 7.25% | -21,0 -20,2 -4.14% | -13,6 -15,3 11.2% | -22,7 -17,0 -33.57% | -21,5 -21,1 -1.79% | -22,7 -20,5 -10.44% | -30,9 -23,0 -34.33% | -17,6 | 0,26 | -8,35 | -9,30 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,2 -20,1 -5.73% | -18,0 -0,38 -4628.42% | -16,4 -20,6 20.67% | -18,3 -18,0 -1.31% | -12,1 -19,1 36.67% | -19,7 -16,1 -22.62% | -18,0 -20,7 12.85% | -19,1 -20,2 5.48% | -24,7 -23,0 -7.39% | -23,2 | -8,45 | -23,7 | -24,1 | |
|
Net income Million USD | Released Forecast Spread | -21,2 -20,5 -3.41% | -18,0 -2,69 -567.96% | -16,4 -19,2 14.72% | -18,3 -17,7 -3.32% | -12,3 -13,8 10.91% | -19,7 -17,0 -15.59% | -18,0 -21,1 14.81% | -19,1 -20,8 8.27% | -24,8 -24,3 -2.01% | -5,70 | -8,08 | -9,20 | -10,4 | |
|
EPS USD | Released Forecast Spread | -0,64 -0,62 -2.56% | -0,40 -0,21 -92.77% | -0,23 -0,37 37.84% | -0,25 -0,27 6.72% | -0,16 -0,21 22.33% | -0,27 -0,24 -13.68% | -0,22 -0,22 0% | -0,17 -0,20 15% | -0,22 -0,20 -10% | -0,12 | -0,09 | -0,13 | -0,13 | -0,17 |
| Announcement Date | 24/03/22 | 16/05/22 | 11/08/22 | 14/11/22 | 15/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 22/03/24 | - | - | - | - | - |
| Today 04:15 pm | PFIZER, INC.: Q1 2024 Earnings Release |
| Today 01:35 am | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 01:35 am | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 02/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
| 03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
Past sector events for HOOKIPA Pharma Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HOOK Stock
- Calendar HOOKIPA Pharma Inc.
